EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Evaluation of photoactivated chromophore for keratitis–corneal cross‐linking (PACK‐CXL) in feline infectious keratitis—patient demographics, treatment protocols, risk factors, and treatment outcome: a retrospective study

Angelie K Shukla iD, Malwina E Kowalska, Kevin Arteaga iD, Manuela Crasta, Christopher Dixon, Frank Famose, Sonja Hartnack, Simon Anton Pot

Veterinary Ophthalmology · 2025

DOI: 10.1111/vop.13228 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Veterinary Ophthalmology, 2025. Verfasst von Angelie K Shukla und 7 weiteren Autor:innen. Beteiligte Einrichtung: Ophthalmology Section, Equine Department, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland. Hauptthemen laut MEDLINE: Cat Diseases, Keratitis, Photosensitizing Agents, Riboflavin. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To describe patient demographics and treatment protocols in a population of feline patients undergoing photoactivated chromophore for keratitis–corneal cross‐linking (PACK–CXL) as an adjunctive treatment for infectious keratitis. Furthermore, to determine the proportion of PACK–CXL treatment success in the population studied, explore risk factors for treatment failure, and provide recommendations for future PACK–CXL clinical studies. Materials and Methods Records from four veterinary ophthalmology practices were reviewed to identify eligible patients and extract data. Recorded variables included patient‐related factors, ocular examination findings, PACK‐CXL protocol parameters, and treatment outcome.

Results

Records for 153 cats (154 eyes) were included. Median age in the treatment success group was 8 years (interquartile range (IQR) 4–12), with a median ulcer depth of 30% (IQR 30–40). Median age in the treatment failure group was 10.5 years (IQR 4.75–12) with a median ulcer depth of 45.9% (IQR 30–75). Persian cats were the most represented brachycephalic breed (52 out of 64 cats). Modified PACK–CXL protocols were used, including fast energy delivery (134 eyes), and increased fluence (52 eyes). The overall proportion of success was 88% (95% CI 84–93), which was variable between clinics. Eighty‐two of 89 mesocephalic cat eyes (92%), and 54 of 65 brachycephalic cat eyes (83%) were classified as treatment successes.

Conclusions

PACK–CXL appeared to be a useful, adjunctive therapeutic modality for the treatment of infectious keratitis in the feline patient population presented here. Brachycephalic cats, older cats, and those with deeper ulcers may be at increased risk for treatment failure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cat DiseasesKeratitisPhotosensitizing AgentsRiboflavinPhotochemotherapyCross-Linking ReagentsAnimalsCatsRetrospective StudiesFemaleMaleRisk FactorsTreatment OutcomeCorneal Cross-Linking

Stichwörter der Autor:innen

Persian catbrachycephaliccorneal cross‐linkingseptic keratitistreatment failureulcer

Substanzen

Photosensitizing AgentsRiboflavinCross-Linking Reagents

Autor:innen und Institutionen

  • Ophthalmology Section, Equine Department, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.
  • Section of Epidemiology, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.
  • AniCura Vision Vet Veterinary Eye Clinic, Bologna, Italy.
  • Veterinary Vision, Penrith, UK.
  • Clinique Vétérinaire d'Ophtalmologie Spécialisée, Blagnac, France.

ORCID-Profile: Angelie K Shukla, Kevin Arteaga

Zitieren

APA

Shukla, A. K., Kowalska, M. E., Arteaga, K., Crasta, M., Dixon, C., Famose, F., Hartnack, S., & Pot, S. A. (2025). Evaluation of photoactivated chromophore for keratitis–corneal cross‐linking (PACK‐CXL) in feline infectious keratitis—patient demographics, treatment protocols, risk factors, and treatment outcome: a retrospective study. Veterinary Ophthalmology. https://doi.org/10.1111/vop.13228

Vancouver

Shukla AK, Kowalska ME, Arteaga K, Crasta M, Dixon C, Famose F, et al. Evaluation of photoactivated chromophore for keratitis–corneal cross‐linking (PACK‐CXL) in feline infectious keratitis—patient demographics, treatment protocols, risk factors, and treatment outcome: a retrospective study. Veterinary Ophthalmology. 2025. doi:10.1111/vop.13228

BibTeX
@article{Shukla2025,
  author = {Shukla, Angelie K and Kowalska, Malwina E and Arteaga, Kevin and Crasta, Manuela and Dixon, Christopher and Famose, Frank and Hartnack, Sonja and Pot, Simon Anton},
  title = {Evaluation of photoactivated chromophore for keratitis–corneal cross‐linking (PACK‐CXL) in feline infectious keratitis—patient demographics, treatment protocols, risk factors, and treatment outcome: a retrospective study},
  journal = {Veterinary Ophthalmology},
  year = {2025},
  doi = {10.1111/vop.13228}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche